Efficacy safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy

Journal of Urology

Volumn 160, Issue 4, 1998, Pages 1325-1328

  Costabile, Raymond A ^a   Spevak, Marianne ^a   Fishman, Irving J ^a   Govier, Fred E ^a   Hellstrom, Wayne J G ^a   Shabsigh, Ridwan ^a   Nemo, Kerry J ^a   Rapport, Joshua L ^a   Tam, Peter Y ^a   Weldon, Kara L M ^a   Gesundheit, Neil ^a  

^a NONE

Author keywords

Alprostadil; Carcinoma; Impotence; Prostatectomy

Indexed keywords

PROSTAGLANDIN E1;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSURIA; ERECTILE DYSFUNCTION; HUMAN; HYPOTENSION; INTRAURETHRAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PENIS ERECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATECTOMY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SEXUAL INTERCOURSE; TREATMENT OUTCOME;

EID: 0032322573     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62527-8     Document Type: Article

References (21)

1. Denmeade, S. R. and Isaacs, J. T.: Prostate cancer: where are we and where are we going? Brit. J. Urol., 79: 2, 1997.
2. SEER Cancer Statistics Review. Bethesda, MD: U. S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute. 1996.
3. Cancer Statistics, 1994. New York: American Cancer Society, 1994.
4. Catalona, W. J. and Basler, J. W.: Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J. Urol., 150: 905, 1993.
5. Geary, E. S., Dendinger, T. E., Freiha, F. S. and Stamey, T. A.: Nerve sparing radical prostatectomy: a different view. J. Urol., 154: 145, 1995.
6. Quinlan, D. M., Epstein, J. I., Carter, B. S. and Walsh, P. C.: Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J. Urol., 145: 998, 1991.
7. Schlegel, P. N. and Walsh, P. C.: Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function. J. Urol., 138: 1402, 1987.
8. Walsh, P. C. and Donker, P. J.: Impotence following radical prostatectomy: insight into etiology and prevention. J. Urol., 128: 492, 1982.
9. Dennis, R. L. and McDougal, W. S.: Pharmacological treatment of erectile dysfunction after radical prostatectomy. J. Urol., 139: 775, 1988.
10. Bahnson, R. R. and Catalona, W. J.: Papaverine testing of impotent patients following nerve-sparing radical prostatectomy. J. Urol., 139: 773, 1988.
11. Murphy, G. P., Mettlin, C., Menck, H., Winchester, D. P. and Davidson, A. M.: National patterns of prostate cancer treatment by radical prostatectomy: results of a survey by the American College of Surgeons Commission on Cancer. J. Urol., 152: 1817, 1994.
12. Polascik, T. J. and Walsh, P. C.: Radical retropubic prostatectomy: the influence of accessory pudendal arteries on the recovery of sexual function. J. Urol., 154: 150, 1995.
13. Formenti, S. C., Lieskovsky, G., Simoneau, A. R., Skinner, D., Groshen, S., Chen, S. C. and Petrovich, Z.: Impact of moderate dose of postoperative radiation on urinary continence and potency in patients with prostate cancer treated with nerve sparing prostatectomy. J. Urol., 155: 616, 1996.
14. Walsh, P. C.: The status of radical prostatectomy in the United States in 1993: where do we go from here? J. Urol., 152: 1816, 1994.
15. Padma-Nathan, H., Hellstrom, W. J., Kaiser, F. E., Labasky, R. F., Lue, T. F., Nolten, W. E., Norwood, P. A., Peterson, C. A., Shabsigh, R., Tam, P. Y. and the Medicated Urethral System for Erection (MUSE) Study Group: Treatment of men with erectile dysfunction with transurethral alprostadil. New Engl. J. Med., 336: 1, 1997.
16. Schover, L. R.: Sexual rehabilitation after treatment for prostate cancer. Cancer, 71: 1024, 1993.
17. Fowler, F. J., Jr., Barry, M. J., Lu-Yao, G., Roman, A., Wasson, J. and Wennberg, J. E.: Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare experience: 1988-1990. Urology, 42: 622, 1993.
18. Lu-Yao, G. L., McLerran, D., Wasson, J. and Wennberg, J. E.: An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. J.A.M.A., 269: 2633, 1993.
19. Zimmern, P. E., Kaswick, J. and Leach, G. E.: How potent is potent before nerve sparing radical retropubic prostatectomy? J. Urol., 154: 1100, 1995.
20. Kaplan, H. S.: The combined use of sex therapy and intrapenile injections in the treatment of impotence. J. Sex. Marital Ther., 16: 195, 1990.
21. Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., Leach, G. E. and Brook, R. H.: Quality-of-life outcomes in men treated for localized prostate cancer. J.A.M.A., 273: 129, 1995.